title: Tamoxifen: a new risk factor for cerebral sinus thrombosis.
authors.affiliation: Department of Neurology, Hospital Ramón y Cajal, Madrid, Spain. jmasjuan@saludalia.com
authors.forename: J
authors.initials: J
authors.lastname: Masjuan
authors.forename: J
authors.initials: J
authors.lastname: Pardo
authors.forename: J M
authors.initials: JM
authors.lastname: Callejo
authors.forename: M T
authors.initials: MT
authors.lastname: Andrés
authors.forename: J C
authors.initials: JC
authors.lastname: Alvarez-Cermeño
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D003221:Confusion / Q000209:etiology; D020847:Estrogen Receptor Modulators / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D012307:Risk Factors; D012851:Sinus Thrombosis, Intracranial / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D018931:Antineoplastic Agents, Hormonal; D020847:Estrogen Receptor Modulators; D013629:Tamoxifen; D006493:Heparin